The risk of death in young and middle-aged adults in Brazil after contracting COVID-19 is on the rise, researchers have found.
The researchers noted that Brazil is currently suffering a “deadly surge” of COVID-19 infections, which has been attributed to the spread of a new strain known as P.1 (B.1.1.28.1).
They examined public COVID-19 data from the southern Brazilian state of Parana—the largest state in the southern half of the country—which has seen a total of 553,518 positive cases from September 2020 through March 17.
From January to February, these rates tripled among COVID-19 patients aged 20 to 29, from 0.04 percent to 0.13 percent, and doubled among those aged 30 to 39, 40 to 49, and 50 to 59.
“Individuals between 20 and 29 years of age whose diagnosis was made in February 2021 had an over three-fold higher risk of death compared to those diagnosed in January 2021,” the researchers said.
“Taken together, these preliminary findings suggest significant increases in case fatality rates in young and middle-aged adults after identification of a novel SARS-CoV-2 strain circulating in Brazil, and this should raise public health alarms.”
It’s unclear what is driving the growing infection rate among Brazil’s younger population. Medical professionals have suggested that limited vaccines and the P.1 variant that first emerged in the city of Manaus late last year, coupled with the UK variant, have contributed to the rise.
The P.1 strain features mutations associated with higher viral infectivity and greater resistance to antibodies—though experts caution that more study is needed to verify the “fitness” of the mutant virus.